FDA Clearance Tracker · P140003-S018
Impella Ventricular Support Systems
Last checked: Nov 20, 2026Latest source record: Feb 7, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Feb 7, 2018
Approved
Time to decision
310 days
Received Apr 3, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P140003-S018
- Device name
- Impella Ventricular Support Systems
- Applicant
- Abiomed, Inc.
- Applicant location
- Danvers, MA
- Received
- Apr 3, 2017
- Decided
- Feb 7, 2018
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P140003
Device type
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the Impella Ventricular Support Systems. The device is indicated for the treatment of ongoing cardiogenic shock that occurs:1) immediately (<48 hours) following acute myocardial infarction or open heart surgery; or2) in the setting of cardiomyopathy, including peripartum cardiomyopathy, or myocarditis.As a result of isolated left ventricular failure that is not responsive to optimal medical management and conventional treatment measures.* The intent of the Impella Support Systems therapy is to reduce ventricular work and to provide the circulatory support necessary to allow heart recovery and early assessment of residual myocardial function.*Optimal medical management and conventional treatment measures include volume loading and use of pressors and inotropes, with or without IABP.
Source documents
Other decisions for Abiomed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252766 · Decided Oct 8, 2025 · 40 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.